122 related articles for article (PubMed ID: 35445730)
1. EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells.
Takeda T; Tsubaki M; Matsuda T; Kimura A; Jinushi M; Obana T; Takegami M; Nishida S
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35445730
[TBL] [Abstract][Full Text] [Related]
2. Curcumin attenuates lncRNA H19‑induced epithelial‑mesenchymal transition in tamoxifen‑resistant breast cancer cells.
Cai J; Sun H; Zheng B; Xie M; Xu C; Zhang G; Huang X; Zhuang J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179087
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway.
Maseki S; Ijichi K; Tanaka H; Fujii M; Hasegawa Y; Ogawa T; Murakami S; Kondo E; Nakanishi H
Br J Cancer; 2012 Mar; 106(6):1196-204. PubMed ID: 22315058
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
5. SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma.
Bossart EA; Tasdemir N; Sikora MJ; Bahreini A; Levine KM; Chen J; Basudan A; Jacobsen BM; Burns TF; Oesterreich S
Breast Cancer Res Treat; 2019 Jun; 175(2):327-337. PubMed ID: 30798422
[TBL] [Abstract][Full Text] [Related]
6. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
[TBL] [Abstract][Full Text] [Related]
7. The Wilms' tumor suppressor WT1 regulates expression of members of the epidermal growth factor receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance.
Wang L; Zhang X; Wang ZY
Anticancer Res; 2010 Sep; 30(9):3637-42. PubMed ID: 20944147
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
Ciupek A; Rechoum Y; Gu G; Gelsomino L; Beyer AR; Brusco L; Covington KR; Tsimelzon A; Fuqua SA
Breast Cancer Res Treat; 2015 Nov; 154(2):225-37. PubMed ID: 26487496
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells.
Li G; Zhang J; Jin K; He K; Zheng Y; Xu X; Wang H; Wang H; Li Z; Yu X; Teng X; Cao J; Teng L
Mol Oncol; 2013 Jun; 7(3):611-24. PubMed ID: 23499324
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells.
Kim S; Lee J; Oh SJ; Nam SJ; Lee JE
Oncol Rep; 2015 Sep; 34(3):1613-9. PubMed ID: 26166014
[TBL] [Abstract][Full Text] [Related]
11. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation.
Moerkens M; Zhang Y; Wester L; van de Water B; Meerman JH
BMC Cancer; 2014 Apr; 14():283. PubMed ID: 24758408
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839).
Hiscox S; Morgan L; Barrow D; Dutkowskil C; Wakeling A; Nicholson RI
Clin Exp Metastasis; 2004; 21(3):201-12. PubMed ID: 15387370
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.
Lo HW; Hsu SC; Xia W; Cao X; Shih JY; Wei Y; Abbruzzese JL; Hortobagyi GN; Hung MC
Cancer Res; 2007 Oct; 67(19):9066-76. PubMed ID: 17909010
[TBL] [Abstract][Full Text] [Related]
15. The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.
Loh YN; Hedditch EL; Baker LA; Jary E; Ward RL; Ford CE
BMC Cancer; 2013 Apr; 13():174. PubMed ID: 23547709
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.
Shou J; Massarweh S; Osborne CK; Wakeling AE; Ali S; Weiss H; Schiff R
J Natl Cancer Inst; 2004 Jun; 96(12):926-35. PubMed ID: 15199112
[TBL] [Abstract][Full Text] [Related]
17. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
18. SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer.
Tripathi SK; Biswal BK
Life Sci; 2021 Jul; 277():119608. PubMed ID: 33989664
[TBL] [Abstract][Full Text] [Related]
19. Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells.
Lee AF; Chen MC; Chen CJ; Yang CJ; Huang MS; Liu YP
PLoS One; 2017; 12(7):e0180383. PubMed ID: 28683123
[TBL] [Abstract][Full Text] [Related]
20. TCRP1 induces tamoxifen resistance by promoting the activation of SGK1 in MCF‑7 cells.
Zhao S; Li X; Yin L; Hou L; Lan J; Zhu X
Oncol Rep; 2020 Jun; 43(6):2017-2027. PubMed ID: 32323833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
